Betts Wendy J 4

What Happened Wendy J. Betts, a director of Cardio Diagnostics Holdings, Inc. (CDIO), was granted a derivative award reported as an acquisition on June 30, 2026. The filing shows 2,854 derivative shares acquired at $2.19 per share, a total reported value of approximately $6,250. This was an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (timely within the 2-business-day window).
• Award: 2,854 derivative shares at $2.19 per share; total ≈ $6,250.
• Transaction type: A (grant/award/other acquisition) — reported as a derivative acquisition.
• Shares owned after the transaction: not specified in the provided excerpt (check the full Form 4 for post-transaction holdings).
• No 10b5-1 plan, tax-withholding, or other footnotes are shown in the provided transaction summary.

Context Derivative awards to directors are commonly part of compensation packages (restricted stock, RSUs, or similar) and are reported on Form 4 as acquisitions; they do not necessarily reflect a personal trading view. For full details (vesting, conversion mechanics, and total holdings), review the complete Form 4 filing.